Special: Wall Street buying frenzy on Under $5 Stock



NVAX: Novavax, Inc. is a Sell

The current rating for NVAX is 48, which is 4% below its historic median rating of 50. This indicates higher risk than normal.

The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.